HbA1c News and Research

RSS
Dapagliflozin as monotherapy demonstrates potential for type 2 diabetes treatment

Dapagliflozin as monotherapy demonstrates potential for type 2 diabetes treatment

Mice treated with XOMA 052 experiences improvement in measures associated with diabetes: Endocrinology

Mice treated with XOMA 052 experiences improvement in measures associated with diabetes: Endocrinology

Study shows vitamin D deficiency is highly prevalent in patients with Type 2 diabetes

Study shows vitamin D deficiency is highly prevalent in patients with Type 2 diabetes

Lexicon presents LX4211 Phase 2a clinical trial results for type 2 diabetes mellitus at ENDO 2010

Lexicon presents LX4211 Phase 2a clinical trial results for type 2 diabetes mellitus at ENDO 2010

Zydus Cadila receives DCGI approval to initiate Phase I clinical trial for ZYOG1

Zydus Cadila receives DCGI approval to initiate Phase I clinical trial for ZYOG1

AFREZZA non-inferior to standard therapy insulin lispro in reducing HbA1c levels of Type 1 diabetics

AFREZZA non-inferior to standard therapy insulin lispro in reducing HbA1c levels of Type 1 diabetics

Additional markers of risk for diabetic microvascular complications beyond Hemoglobin A1c needed

Additional markers of risk for diabetic microvascular complications beyond Hemoglobin A1c needed

Off-label use of AAs among elderly associated with increased risk of diabetes: Study

Off-label use of AAs among elderly associated with increased risk of diabetes: Study

Additional benefits of LAIAs over long-acting human insulin not been proven

Additional benefits of LAIAs over long-acting human insulin not been proven

Transition Therapeutics reports increased revenue in third-quarter 2010

Transition Therapeutics reports increased revenue in third-quarter 2010

Harbor BioSciences reports encouraging results from Triolex Phase IIa trials

Harbor BioSciences reports encouraging results from Triolex Phase IIa trials

Lexicon Pharmaceuticals first-quarter revenues down 61%

Lexicon Pharmaceuticals first-quarter revenues down 61%

Researchers analyze spine surgery patients' existing comorbdities in relationship to hospital stay, costs

Researchers analyze spine surgery patients' existing comorbdities in relationship to hospital stay, costs

HbA1c can be deceptive in African American children with diabetes: Study

HbA1c can be deceptive in African American children with diabetes: Study

MannKind reports first-quarter net loss of $44.7 million applicable to common stockholders

MannKind reports first-quarter net loss of $44.7 million applicable to common stockholders

Roche announces results of phase III T-emerge 3 study of taspoglutide in diabetics

Roche announces results of phase III T-emerge 3 study of taspoglutide in diabetics

Highlights from AACE 19th Annual Meeting and Clinical Congress

Highlights from AACE 19th Annual Meeting and Clinical Congress

Research associates diabetes with atrial fibrillation

Research associates diabetes with atrial fibrillation

Research article reports association of chronic upper GI symptoms with diabetes

Research article reports association of chronic upper GI symptoms with diabetes

Obese patients may receive higher rate of recommended care than normal-weight patients, but not lower

Obese patients may receive higher rate of recommended care than normal-weight patients, but not lower